18 March, 2025 Cyrano Therapeutics and Resyca announce exclusive license agreement for soft mist nasal spray technology for the treatment of persistent smell loss Read More
04 October, 2024 Aero Pump and Resyca partner to launch Ultra Soft Nasal Pump Spray, targeting precise nasal drug delivery applications Read More
18 July, 2024 Silo Pharma and Resyca BV partner on device and CMC development for intranasal PTSD drug SPC-15 Read More
03 April, 2024 Resyca shareholder Bespak announces successful completion of spin-out from Recipharm Group Read More
23 January, 2024 Recipharm, Medspray and Resyca enter into exclusive licence agreement to develop nasally-delivered drug products using proprietary soft mist technology Read More
14 June, 2023 Thaerapy BV and Resyca BV announce exclusive licence agreement for Soft Mist Inhaler technology Read More
